Hot Investor Mandate: USA Family Office Invests Up to $5M in Early-Stage Life Science Technologies in North America

18 Oct

A family office based in the USA invests in life science companies at the Seed or Series A stage. The firm will consider opportunities throughout the US and Canada but has a focus on the US East Coast and Midwest. The firm’s investment size ranges from $100,000-$250,000 for seed rounds up to as much as $5 million for Series A opportunities, and the firm may also participate in follow-on investments for their portfolio companies.

The firm is interested in medtech, diagnostics, digital health, biotech, and other applications in life sciences such as technologies that improve lab processes. The firm also has interest in therapeutic platform opportunities, but less in companies developing single drug assets. The firm is open to investing in early stage technologies, including devices that have yet to enter human clinical trials.

The firm will consider investing in companies that have obtained data from a prototype, pilot study, or early stage clinical trial. The firm will also consider investing in management teams that have a successful track record with similar types of technologies and targets.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: